Loading...
Age-related trends in injection site reaction incidence induced by the tumor necrosis factor-α (TNF-α) inhibitors etanercept and adalimumab: the Food and Drug Administration adverse event reporting system, 2004-2015
Tumor necrosis factor-α (TNF-α) inhibitors are increasingly being used as treatment for rheumatoid arthritis (RA). However, the administration of these drugs carries the risk of inducing injection site reaction (ISR). ISR gives rise to patient stress, nervousness, and a decrease in quality of life (...
Na minha lista:
| Udgivet i: | Int J Med Sci |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Ivyspring International Publisher
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5332837/ https://ncbi.nlm.nih.gov/pubmed/28260984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.17025 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|